The role of patient engagement in shaping paediatric research - ERDERA Planning of the 2027 Training Course for Young Rare Diseases Patients Advocates – Panel Discussion with ERDERA Experts and Young Representatives

The session brought together young representatives, patient advocates and experts to reflect on the first edition of the ERDERA -Young Patients Training (Athens 2025) and second edition of the ERDERA Training for Young Advocates for Rare Disease (Paris 2026), and to identify priorities for future editions. Participants shared their experiences, discussed how training strengthened their knowledge, confidence and self-advocacy skills, and explored opportunities for meaningful youth involvement through co-production, co-design and continued dialogue with researchers. The discussion highlighted recommendations for the 2027 training programme, emphasising accessible scientific information, mentorship and sustained opportunities for young people to shape paediatric and rare disease research.

Experts:

Suja Somanadhan

Read more

Dr. Suja Somanadhan is an Associate Professor in Children’s Nursing at University College Dublin, Ireland, with over 20 years of experience as a nurse practitioner and more than 15 years dedicated to paediatric health research. 

Aleksander Wiśniewski

Read more

Aleksander Wiśniewski, PhD — nurse, researcher and Head of the Clinical Trials Unit at the Children’s Memorial Health Institute in Warsaw. Coordinator of POLPEDNET, the Polish Paediatric Clinical Trials Network, and advocate for young patients’ involvement in research through POLPEDNET KIDS. His interests include paediatric clinical research, medical innovation and the role of AI in improving children’s care.

Alessandra Simonetti

Read more

MD and Pediatrician by training, PhD in Immunology and Applied Biotechnology, Master’s degree in Maternal-Child Bioethics, Assistant Professor at University of Rome Tor Vergata, where I lead five modules across various degree programs, a Master’s course, and a Post-Graduate Course.

Over 15 years of experience both in profit and no-profit clinical trials and pediatric drug development at the Clinical Trial Center (CTC) of the IRCCS Bambino Gesù Children’s Hospital, where I have worked for more than two decades.

Actually Medical Director of the CTC’s Phase I Unit, following the requested certificationed as per Italian law.

I also collaborate with the Clinical Trials Department on the development of pediatric drugs, vaccines, and medical devices at the same IRCCS.

For at least ten years, I have given my contribution as an EMA expert at EMA “European Medicine Agency” in evaluating PIPs “Pediatric Investigation Plans” and currently I am C4C-S Expert in C4C-S “conect4children Stichting”, a pioneering pan-European network dedicated to paediatric clinical trials.

Having collaborated with the organization since its creation in 2017, I then became President of INCiPiT (Italian Network for Paediatric Clinical Trials) since October 2025. The network acts as the Italian coordinating center and is dedicated to the promotion, planning, and management of pediatric clinical trials (both for-profit and non-profit). It heads a consortium of 13 members and various affiliates, serving as a hub and point of contact for dedicated European networks.

Eleonora Passeri

Read more

Eleonora Passeri an expert in patient advocacy, rare diseases, science communication, and policy. Dr Passeri is a neuroscientist by education and training with a master’s degree in Molecular Biology (University of Perugia – Italy), a PhD in Neuroscience as Marie Curie fellow (University of Tübingen – Germany), and post-doctoral research studies in the US (McLean Hospital – Boston, Georgetown University – Washington DC, and Johns Hopkins Hospital – Baltimore). 

Later, she has gained a deeper understanding of patient advocacy and international patient organizations/associations by being the communication manager at the European Reference Network (ERN) ReCONNET, the European Joint Program on Rare Diseases (EJP RD) and the International Rare Diseases Research Consortium (IRDiRC); she was a communication consultant for the European Pediatric Translational Research Infrastructure (EPTRI) and CVBF, she also supported the patient advocacy initiatives carried on by TEDDY Network.

In parallel, Dr Passeri increased her research competences by becoming a scientific expert for the European Union (EU) – REA program – and a Medical and Scientific Advisory Board of the Ghana Initiative for Rare Diseases as well as a healthcare professional expert at EMA. Furthermore, she extended her advocacy, policy, and leadership skills by being i) the vice coordinator of Comitato Nazionale Malattie Rare (CoNaMR), National Rare Disease Committee instituted by the Italian Ministry of Health; ii) the founder of the “Rare Special Powers” (RSP) not-for-profit association focused on raising awareness of rare diseases and/or neurodevelopmental disorders; iii) a former member of the “Osservatorio sulla condizione delle persone con disabilità della Regione Umbria”.Moreover, Dr Passeri is a member of the CUPID (Cancer Understanding Prevention in Intellectual Disabilities) COST Action and was a former deputy leader for public awareness at COST Action MINDDS (Maximizing Impact of research in NeuroDevelopmental Disorders).

She earned a Patient Advocacy Management Master from the Università Cattolica del Sacro Cuore in Rome; full fellowship award. Also, she did a training course on bioethics organized by the Università Cattolica del Sacro Cuore.During this time, Dr Passeri participated in numerous events, congresses, conventions, meetings to share her knowledge and skills as well as to learn additional competences. 

Annegret Dahlmann-Noor

Read more

Annegret Dahlmann-Noor is Professor of Paediatric Ophthalmology at University
College London (UCL), Consultant Paediatric Ophthalmologist at Moorfields Eye Hospital and Bedford Hospital, and Vice-President of the European Myopia Society (EUMYS).

She is an NIHR Senior Clinical and Practitioner Research Award holder and an internationally recognised clinician-scientist specialising in childhood myopia.
Her research spans clinical trials, population health and laboratory science, with the shared goal of improving outcomes for children with myopia and reducing the risk of lifelong sight loss. She leads studies investigating new approaches to slowing myopia progression, explores the biological mechanisms that regulate eye growth, and examines how environmental and socioeconomic factors influence the development of myopia in children.

Professor Dahlmann-Noor is passionate about ensuring that advances in myopia management are accessible to all children, regardless of their background. She works closely with ophthalmologists, optometrists, orthoptists, scientists and families to translate research into clinical practice and improve access to evidence-based care. She also co-founded the Eye Young People & Advisory Group (Eye-YPAG), enabling children and young people to help shape vision research and ensuring that their voices are heard in the development of future treatments and services.

Ines Alves

Read more

Founder and president of ANDO Portugal, the Skeletal Dysplasia National Association.
Member of the Committee for Orphan Medicinal Products (COMP) at the European Medicine Agency (EMA) as patient representative.
Member of Patients and consumers working party (PCWP) representing the COMP at the EMA.

Representative of the European Patient Advocacy groups (ePAG) at the European Reference Network for Rare Bone diseases (ERN BOND).
EUPATI fellow, trainer and EUPATI Portugal Vice-President.
Ph.D. candidate in Human Kinetics.
Invited assistant in the School of Health and Human Development, University of Évora.
Research member of the Comprehensive Health Research Center.
Expert evaluator of European grant call proposals in rare diseases.
Orcid ID 0000-0001-8963-4736

Manika Kreka

Read more

Manika Kreka is a Full Professor of Pediatrics in University of Medicine in Tirana, Faculty of Medicine and works as well in University Hospital Center “Mother Teresa”. She has more than 20 years working in academic field.
She has a strong focus of interest in congenital blood disorders , particularly in the field of hemoglobinopathies such as Thalassemia, Sickle Cell Disease, Combinations and all complications related to these pathologic conditions (cardiac , gastric, hepatic, endocrinological and reproductive issues etc).

Prof. Manika is Medical Director of a CRO – Clinical Validation from Biopharmaceutical Findings(CVBF AL) in Tirana since 2017.
She has been involved in various educational and research roles, including serving as Vice Dean for Master Program in Faculty of Medical and Technical Sciences, in University of Medicine. She held a position of Head of the Department of Clinical Sciences in the same institution, in a four year period of time.
Prof Manika Kreka has also been involved in writing articles and has led research (Clinical Trials as Principal Investigator) in Thalassemia and Haemoglobinopathies field, in internationally level. Her contributions to the medical field are recognized through her active participation in scientific sessions and round tables , as well as her extensive body of work in the pediatric and hematology field.

 Mariagrazia Felisi

Read more

Mariagrazia Felisi currently serves as Chief Executive Officer at Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF), where she leads the organization’s activities and ensures the highest standards in clinical research and project execution.

She is a member of the Board of Directors of TEDDY,  where she previously served as Chair and now holds the role of Past President.

She earned a Master’s Degree in Life Sciences, followed by a PhD in Clinical Pharmacology from the University of Bari in 2002 and a Master’s Degree in Pharmacovigilance from the University of Florence in 2003.

Mariagrazia has conducted extensive research in the paediatric field, with a focus on clinical pharmacology, pharmacovigilance, and the management of disease registries. Through these experiences, she has developed deep expertise in clinical research. She has been involved in numerous national and international research projects, frequently taking on leadership roles in clinical trial activities.

Viviana Giannuzzi

Read more

PharmD, PhD in cellular biochemistry and pharmacology, post-graduate master in Clinical Research of Medicines.
My main areas of expertise are: ethics and regulatory, for rare and paediatric diseases, informed consent and assent, health data processing for research purposes, European medicine regulatory procedures.

Currently, I coordinate the Research Innovation Department of Fondazione per la Ricerca Farmacologica Gianni Benzi and participate in international and national research projects and consortia; in most of them, I lead the ethics and regulatory activities. I am member of the Paediatric Committee, European Medicine Agency (EMA), as delegate of the European Commission to represent patient organisations.

I am member of international groups: EMA Patients and Consumers Working Party (PCWP);
European Platform for Regulatory Science Research, INHERENT (International Hemoglobinopathy Research Network), TEDDY network (The European Network of Excellence for Paediatric Research), EURORDIS Therapeutic Action Group, Regulatory Ethics workstream of GA4GH, EPTRI (European Paediatric Transnational Research Infrastructure).

I also joined paediatric working groups, e.g. Ethics Working Group of EnprEMA; Working Group on Rare Cancers of ECPC (European Cancer Patient Coalition); paediatric pharmacology Working Group of the Italian Society of Pharmacology.
Author/co-author of peer reviewed publications and abstracts, reviewer for indexed journals and speaker at national and international congresses/meetings in the relevant fields of expertise.

Young Representative:

Anano Lartsuliani

Read more

Anano Lartsuliani is a young patient and disability advocate and digital designer from Georgia, living with spinal muscular atrophy (SMA). She is actively involved in improving access to information, treatment, support, and inclusion for people with disabilities and those living with SMA in Georgia. She is the founder of SMA Georgia, a Georgian-language informational platform dedicated to the SMA community, and is also a member of the TEDDY Network’s Paediatric Patients Expert Group (PEG). Anano is passionate about meaningful patient involvement, disability rights, and building stronger connections between patients, healthcare professionals, researchers, and organizations.

Aaisha-Seddika Muminah

Read more

Aaisha Seddika Muminah is a 16 year old patient advocate who was misdiagnosed with her rare diseases of Vernal Kerato conjunctivitis and Blepharitis, when she claimed access to Moorfeilds eye Hospital she soon became part of a young peoples advisory group called Eye-YPAG within the Moorefields hospital, which allowed Muminah to become part of TEDDY, ICAN, INVENTS and ERDERA.

Francesco Meloni

Read more

Francesco Meloni is a 14-year-old student from Sardinia, Italy, and an active member of the Italian Bladder Exstrophy-Epispadias Association (AEV). In April 2026, he participated in the ERDERA Training for Young Advocates for Rare Diseases in Paris.

He is also a young patient representative on the Patient Advisory Board (PAB) of the GAPP project.
Through online meetings with other members of the board, he has contributed to the review of the research protocol, sharing the patient perspective and helping ensure that patients needs and experiences are considered in the research process.
Through these experiences, Francesco is committed to giving young patients a voice and promoting their active involvement in research.

Eirini Daskalopoulou

Read more

Eirini Daskalopoulou is a lawyer with an MSc in Bioethics and Medical Law from Aristotle University of Thessaloniki, Greece, specializing in the intersection of law, ethics and healthcare innovation. She serves as General Secretary of the Panhellenic Advocate for Inherited Metabolic Diseases “KRIKOS ZOIS” and leads KIDS RARE HELLAS, the Young Patient Advisory Group within the TEDDY KIDS Network.

A dedicated advocate for people living with rare and undiagnosed diseases, Eirini actively contributes to national, European and international initiatives aimed at strengthening patient engagement, advancing health policy and promoting equitable access to care. In 2024, she was selected as a EURORDIS Young Ambassador, representing the voice of young patients at  European events and policy forums.

She is a graduate of the Rare Diseases Academy of Rare Diseases Greece and is currently participating in the EUPATI Training Programme through the Greek Patients’ Association, further strengthening her expertise in medicines development and patient involvement. Eirini also serves as a Reviewer in the Global Network for Rare Diseases (GNRD) Working Group on Care Pathways for Rare Diseases International, contributing to the development of more inclusive, patient-centered and globally relevant care pathways for people living with rare diseases.

Karol Słowik

Leonardo Fiore

Read more

Leonardo Fiore is a student at the Gaetano Salvemini scientific high school in Bari. He joined the KIDS Bari YPAG in 2023 and has participated in numerous advocacy activities. In April 2025, he participated as a young advocate at the Mid-Term Review Conference of the Strategy for the Rights of the Child, held in Strasbourg at the Council of Europe. During the conference, after he took part in creating a new child-friendly guide to inform children about their participation in decisions regarding their healthcare, he served as a co-moderator in the discussion with medical professionals about the guide.

As a member of KIDS Bari  (the first italian Young Person Advisory Group of the international iCAN network), Leonardo collaborates with doctors, researchers, and institutions. The group’s mission is to give youth a voice in pediatric research, ensuring that clinical trials and healthcare policies are tailor-made for minors.

Thuraya Layla Pearl Derby

Read more

Thuraya Derby is a young advocate from Moorfields Eye-YPAG within the TEDDY KIDS Network. She enjoys  being a speaker as it is a great opportunity to get your her voice heard. Besides being part of TEDDY, she also participated and is a member of ICAN, INVENTS’ PEG, GAPP’s PAB and ERDERA.

Valentina Jalby

Read more

Valentina Jalby is a young rare disease patient advocate who represents the youth perspective in pediatric clinical research through the TEDDY Kids Network and the Patient Expert Group for the INVENTS Project.